DAs not only decrease PRL secretion but also downregulate PRL gene expression in pituitary cells, resulting in a decrease in the number of PRL secretory granules, vacuolation of secretory cells [14], cell death including apoptosis [15], and bromocriptine-induced tumor fibrosis [16]. Here, PRL is linked to neoplasm.